Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AARTIDRUGS.NSthis companyAarti Drugs Limited	₹499.75	14.97×	1.88×	1.14×	11.19×	-76.9%	29.2%	9.4%	7.6%	12.6%	10.1%	1.7%	0.37×	1.82×	7.19×	1.59×	0.6%	4	3.46	2	C
AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited	₹109.04	36.51×	0.96×	0.31×	14.58×	-99.9%	3.0%	0.9%	0.8%	2.6%	1.6%	-16.1%	0.33×	3.66×	0.86×	1.81×	0.0%	6	—	2	C
AARTIPHARM.NSAarti Pharmalabs Limited	₹921.40	32.96×	2.71×	3.16×	16.93×	-152.7%	54.1%	16.4%	9.6%	8.2%	7.3%	-3.2%	0.36×	1.94×	6.36×	1.49×	0.6%	6	4.24	3	B-
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
ANUHPHR.NSAnuh Pharma Limited	₹82.78	16.37×	1.91×	0.87×	10.04×	12.6%	17.4%	6.5%	5.3%	11.7%	10.8%	-1.6%	0×	-0.12×	106.58×	2.22×	2.2%	—	—	2	C
BAJAJHCARE.NSBajaj Healthcare Ltd	₹315.25	58.25×	1.72×	1.5×	14.35×	-51.1%	33.4%	12.6%	2.6%	3.0%	7.2%	-0.7%	0.47×	2.68×	3.48×	1.71×	0.3%	2	2.61	2	C+
Peer median	—	32.96×	1.91×	1.5×	14.44×	-51.1%	33.4%	12.6%	5.3%	8.2%	7.3%	-1.6%	0.33×	1.94×	6.36×	1.81×	0.5%	6	3.42	2	—